CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 64 filers reported holding CONATUS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $23,000 | +53.3% | 74,208 | +95.2% | 0.00% | – |
| Q4 2019 | $15,000 | +400.0% | 38,017 | +297.7% | 0.00% | – |
| Q3 2019 | $3,000 | +50.0% | 9,559 | +29.3% | 0.00% | – |
| Q2 2019 | $2,000 | -88.2% | 7,393 | -52.5% | 0.00% | – |
| Q1 2019 | $17,000 | +6.2% | 15,548 | +69.5% | 0.00% | – |
| Q4 2018 | $16,000 | -68.6% | 9,174 | +3.5% | 0.00% | – |
| Q3 2018 | $51,000 | +41.7% | 8,862 | +5.8% | 0.00% | – |
| Q2 2018 | $36,000 | -18.2% | 8,379 | +12.8% | 0.00% | – |
| Q1 2018 | $44,000 | +780.0% | 7,430 | +548.3% | 0.00% | – |
| Q4 2017 | $5,000 | -44.4% | 1,146 | -27.9% | 0.00% | – |
| Q3 2017 | $9,000 | -43.8% | 1,590 | -41.0% | 0.00% | – |
| Q1 2017 | $16,000 | -48.4% | 2,696 | -53.8% | 0.00% | – |
| Q4 2016 | $31,000 | +1450.0% | 5,840 | +386.7% | 0.00% | – |
| Q3 2016 | $2,000 | -80.0% | 1,200 | -74.5% | 0.00% | – |
| Q2 2016 | $10,000 | 0.0% | 4,711 | +42.1% | 0.00% | – |
| Q4 2015 | $10,000 | +100.0% | 3,315 | +231.5% | 0.00% | – |
| Q2 2015 | $5,000 | -84.8% | 1,000 | -78.2% | 0.00% | – |
| Q1 2015 | $33,000 | +37.5% | 4,591 | +35.6% | 0.00% | – |
| Q4 2014 | $24,000 | – | 3,386 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JBF Capital, Inc. | 520,553 | $161,000 | 0.03% |
| Kalos Management, Inc. | 43,940 | $13,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 1,351,000 | $419,000 | 0.00% |
| Quilter Plc | 60,546 | $19,000 | 0.00% |
| ALBION FINANCIAL GROUP /UT | 12,000 | $4,000 | 0.00% |
| REILLY FINANCIAL ADVISORS, LLC | 22,011 | $7,000 | 0.00% |
| MORGAN STANLEY | 1,900 | $1,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 24,900 | $8,000 | 0.00% |
| BlackRock Inc. | 645,611 | $200,000 | 0.00% |
| Bank of New York Mellon Corp | 137,500 | $43,000 | 0.00% |